The end of profiling as you know it.

Stop asking, “What can I measure?” Start asking, “What should I measure?” Thanks to nCounter® Vantage 3D™ assays, you get the full picture—targeted DNA, RNA, and protein analyses in one process. Why compromise when you don’t have to? Stop performing sequential testing.

How it works

3D Biology Applications

Multi-analyte profiling designed for your solid tumor research. With DNA panels to analyze mutational status combined with RNA and protein expression profiling, you can learn more from less sample. Our assays designed for Solid Tumor profiling are part of the nCounter® Vantage 3D™ portfolio, allowing for multiple multi-analyte assay designs for use with many limited sample types, such as lysate and FFPE.
Now you can simultaneously analyze gene and protein expression for up to 800 targets on the nCounter® System. With content designed for immune profiling, the nCounter Vantage RNA:Protein Immune assays give you an integrated view of the biology you’re interested in. Analysis is preformed with as few as 20,000 cells (up to 50,000 cells for PBMCs and primary cells) and this sensitive technique enables you to make new connections while saving time and resources.
Why Compromise?
Capture more biology from less sample. With as few as 5,000 cells, you can simultaneously profile any combination of SNVs, RNA, and protein targets.
nCounter® Vantage 3D™ Brochure
See our complete portfolio of nCounter® Vantage 3D™ Assays and learn how 3D Biology technology can help you get more results from your sample.

Register for our nCounter® Vantage 3D™ Assay Webinar


Advancing Tumor Profiling with nCounter® Vantage 3D™ Assays


Wednesday, May 25th


Gavin Meredith, Associate Director of Product Development, NanoString Technologies

Niro Ramachandran, Director of Product Management, NanoString Technologies


Contact Us
Connect with our experts to understand how 3D Biology™ and the nCounter® Vantage 3D™ assay portfolio may accelerate your research.

Subscribe for email updates from NanoString